Martine Rothblatt

2009

In 2009, Martine Rothblatt earned a total compensation of $17.6M as Chief Executive Officer at United Therapeutics, a 216% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,755,503
Non-Equity Incentive Plan$440,125
Option Awards$14,577,981
Salary$798,203
Other$19,286
Total$17,591,098

Rothblatt received $14.6M in option awards, accounting for 83% of the total pay in 2009.

Rothblatt also received $1.8M of change in pension value and nonqualified deferred compensation earnings, $440.1K in non-equity incentive plan, $798.2K in salary and $19.3K in other compensation.

Rankings

In 2009, Martine Rothblatt's compensation ranked 74th out of 9,885 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.3% of executives.

ClassificationRankingPercentile
All
74
out of 9,885
99th
Division
Manufacturing
24
out of 3,690
99th
Major group
Chemicals And Allied Products
10
out of 871
99th
Industry group
Drugs
10
out of 643
98th
Industry
Pharmaceutical Preparations
10
out of 446
98th
Source: SEC filing on April 30, 2012.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2009.

2009

Roger Jeffs

United Therapeutics

Chief Operating Officer

2009

Paul Mahon

United Therapeutics

General Counsel

2009

John Ferrari

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like